RESUMEN

Ebola viruses (family: Filoviridae) are the cause of Ebola virus disease (EVD), a highly fatal illness characterised by haemorrhagic fever syndrome in both humans and non-human primates (NHPs). West Africa was the epicentre of the 2013-2015 EVD epidemic which caused the death of over 11,000 people, including eight casualties in southern Nigeria. Antibodies to filoviruses have been detected among NHPs in some countries, but there is no documented evidence of exposures to filoviruses among NHPs in Nigeria. From August 2015 to February 2017, a total of 142 serum samples were obtained from individual captive and wild animals, belonging to 11 NHP species, in southern Nigeria, and screened for species-specific antibodies to filoviruses belonging to the species; Zaire ebolavirus [Ebola virus (EBOV)], Sudan ebolavirus [Sudan virus (SUDV)], and Marburg marburgvirus [Ravn virus (RAVV)]-using a modified filovirus species-specific ELISA technique. Of the sera tested, 2.1% (3/142) were positive for antibodies to EBOV. The entire 142 sera were negative for SUDV or RAVV. These findings point to the existence of natural exposures of NHPs in southern Nigeria to EBOV. There is need to discourage, the uncontrolled hunting of NHPs in Nigeria for public health safety.

Asunto(s)

Anticuerpos Antivirales/sangre , Fiebre Hemorrágica Ebola/epidemiología , Primates/inmunología , Animales , Ebolavirus/inmunología , Ebolavirus/aislamiento & purificación , Monitoreo Epidemiológico , Humanos , Marburgvirus/inmunología , Marburgvirus/aislamiento & purificación , Nigeria/epidemiología , Salud Pública/métodos

RESUMEN

Immune responses against multiple epitopes are required for the prevention of hepatitis C virus (HCV) infection, and the progression to phase I trials of candidates may be guided by comparative immunogenicity studies in non-human primates. Four vectors, DNA, SFV, human serotype 5 adenovirus (HuAd5) and Modified Vaccinia Ankara (MVA) poxvirus, all expressing hepatitis C virus Core, E1, E2 and NS3, were combined in three prime-boost regimen, and their ability to elicit immune responses against HCV antigens in rhesus macaques was explored and compared. All combinations induced specific T-cell immune responses, including high IFN-γ production. The group immunized with the SFV+MVA regimen elicited higher E2-specific responses as compared with the two other modalities, while animals receiving HuAd5 injections elicited lower IL-4 responses as compared with those receiving MVA. The IFN-γ responses to NS3 were remarkably similar between groups. Only the adenovirus induced envelope-specific antibody responses, but these failed to show neutralizing activity. Therefore, the two novel regimens failed to induce superior responses as compared with already existing HCV vaccine candidates. Differences were found in response to envelope proteins, but the relevance of these remain uncertain given the surprisingly poor correlation with immunogenicity data in chimpanzees, underlining the difficulty to predict efficacy from immunology studies.

Asunto(s)

Linfocitos B/inmunología , Epítopos/genética , Hepacivirus/inmunología , Linfocitos T/inmunología , Vacunas contra Hepatitis Viral/inmunología , Adenoviridae/genética , Animales , Línea Celular , Cricetinae , Epítopos/inmunología , Vectores Genéticos/genética , Inmunogenicidad Vacunal , Interferón gamma/sangre , Interleucina-4/sangre , Macaca mulatta , Masculino , Virus Vaccinia/genética , Vacunas contra Hepatitis Viral/genética

RESUMEN

Tripartite motif 5α (TRIM5α) is a potent antiretroviral immune factor present in the cytoplasm of cells of most tissue types. The rhesus macaque TRIM5 gene has been shown to display polymorphism, with different variants being divided into three groups (TRIM5(TFP), TRIM5(Q), and TRIM5(CypA)), which may have divergent retroviral effects on infection. Along with rhesus macaques, cynomolgus macaques are also used in simian immunodeficiency virus (SIV) infection studies. As a consequence, TRIM5 genotyping of these animals will contribute to interpreting the outcome of such studies. The present communication covers Burmese, Chinese, and a large cohort of Indian-origin rhesus macaques, and describes the first large cohort study on TRIM5 polymorphism in outbred cynomolgus macaques. We demonstrate the presence of the TRIM5(TFP) group in cynomolgus macaques. In addition, we have re-evaluated historical samples of rhesus macaques challenged with SIV(mac251), a virus that has been reported to be partially suppressed by particular rhesus macaque TRIM5 variants.

Asunto(s)

Alelos , Proteínas Portadoras/genética , Macaca mulatta/genética , Polimorfismo Genético , Vacunas contra el SIDAS/inmunología , Síndrome de Inmunodeficiencia Adquirida del Simio/genética , Virus de la Inmunodeficiencia de los Simios , Animales , Asia Sudoriental , Proteínas Portadoras/inmunología , Genotipo , Macaca fascicularis , Macaca mulatta/inmunología , Vacunas contra el SIDAS/genética , Síndrome de Inmunodeficiencia Adquirida del Simio/inmunología , Síndrome de Inmunodeficiencia Adquirida del Simio/prevención & control

RESUMEN

BACKGROUND AND METHODS: To investigate the seroprevalence of polyomavirus infections in macaques, we analyzed 1579 sera from nine different species for antibodies cross-reactive with simian virus 40 (SV40) in an enzyme-linked immunosorbent assay. Most samples were collected from captive animals, but we also investigated a colony of free-ranging Barbary macaques (Macaca sylvanus). RESULTS: High seropositive rates were found in rhesus macaques (Macaca mulatta; 74.7%), cynomolgus macaques (Macaca fascicularis; 44.8%) and Tonkean macaques (Macaca tonkeana; 41.7%), especially in animals imported from China. Low rates were measured in cynomolgus macaques from Mauritius (8.8%), and in Barbary macaques (1.4%). Seropositivity was age-dependent increasing to >70% in animals of 5 years and older. CONCLUSIONS: High seroprevalence rates were found in different species of macaques, dependent on their origin. Very low infection rates found in Barbary macaques and cynomolgus macaques from Mauritius suggest that these animals in the wild are not commonly infected by SV40-like viruses.

Asunto(s)

Animales Salvajes , Animales de Zoológico , Anticuerpos Antivirales/sangre , Macaca/virología , Infecciones por Polyomavirus/veterinaria , Animales , Proteínas de la Cápside/inmunología , Mauricio/epidemiología , Infecciones por Polyomavirus/epidemiología , Estudios Seroepidemiológicos

RESUMEN

Prophylactic hepatitis C virus (HCV) vaccine trials with human volunteers are pending. There is an important need for immunological end points which correlate with vaccine efficacy and which do not involve invasive procedures, such as liver biopsies. By using a multicomponent DNA priming-protein boosting vaccine strategy, naïve chimpanzees were immunized against HCV structural proteins (core, E1, and E2) as well as a nonstructural (NS3) protein. Following immunization, exposure to the heterologous HCV 1b J4 subtype resulted in a peak of plasma viremia which was lower in both immunized animals. Compared to the naïve infection control and nine additional historical controls which became chronic, vaccinee 2 (Vac2) rapidly resolved the infection, while the other (Vac1) clearly controlled HCV infection. Immunization induced antibodies, peptide-specific gamma interferon (IFN-gamma), protein-specific lymphoproliferative responses, IFN-gamma, interleukin-2 (IL-2), and IL-4 T-helper responses in both vaccinees. However, the specificities were markedly different: Vac2 developed responses which were lower in magnitude than those of Vac1 but which were biased towards Th1-type cytokine responses for E1 and NS3. This proof-of-principle study in chimpanzees revealed that immunization with a combination of nonstructural and structural antigens elicited T-cell responses associated with an alteration of the course of infection. Our findings provide data to support the concept that the quality of the response to conserved epitopes and the specific nature of the peripheral T-helper immune response are likely pivotal factors influencing the control and clearance of HCV infection.

Asunto(s)

Hepacivirus/inmunología , Hepatitis C Crónica/prevención & control , Células TH1/inmunología , Células Th2/inmunología , Vacunas contra Hepatitis Viral/inmunología , Animales , Citocinas/biosíntesis , Hepacivirus/patogenicidad , Anticuerpos contra la Hepatitis C/sangre , Antígenos de la Hepatitis C/inmunología , Hepatitis C Crónica/inmunología , Humanos , Inmunización , Activación de Linfocitos/inmunología , Pan troglodytes , Proteínas del Núcleo Viral/inmunología , Vacunas contra Hepatitis Viral/administración & dosificación , Proteínas no Estructurales Virales/inmunología

RESUMEN

A retrospective study spanning 20 years was undertaken to investigate the prevalence and modes of transmission of a simian T-cell lymphotropic virus (STLV) in a closed breeding colony of chimpanzees. Of the 197 animals tested, 22 had antibodies that were cross-reactive with human T-cell lymphotropic virus type-1 (HTLV-I) antigens. The specificity of the antibody response was confirmed by Western blot analysis and the presence of a persistent virus infection was established by PCR analysis of DNA from peripheral blood mononuclear cells. Sequence analysis revealed that the virus infecting these chimpanzees was not HTLV-I but STLV(cpz), a virus that naturally infects chimpanzees. The limited number of transmission events suggested that management practices of social housing of family units away from troops of mature males might have prevented the majority of cases of transmission. Evidence for transmission by blood-to-blood contact was documented clearly in at least one instance. In contrast, transmission from infected mother to child was not observed, suggesting that this is not a common route of transmission for STLV in this species, which is in contrast to HTLV-1 in humans.

Asunto(s)

Enfermedades del Simio Antropoideo/transmisión , Infecciones por Deltaretrovirus/veterinaria , Pan troglodytes , Virus Linfotrópico T Tipo 1 de los Simios/genética , Animales , Anticuerpos Antivirales/sangre , Enfermedades del Simio Antropoideo/sangre , Enfermedades del Simio Antropoideo/virología , Infecciones por Deltaretrovirus/transmisión , Transmisión de Enfermedad Infecciosa , Femenino , Virus Linfotrópico T Tipo 1 Humano/inmunología , Leucocitos Mononucleares/virología , Masculino , Datos de Secuencia Molecular , Filogenia , Reacción en Cadena de la Polimerasa , Prevalencia , Estudios Retrospectivos , Factores Sexuales , Virus Linfotrópico T Tipo 1 de los Simios/química , Virus Linfotrópico T Tipo 1 de los Simios/clasificación , Proteínas del Envoltorio Viral/genética

RESUMEN

Mitochondrial DNA control region sequences of orangutans (Pongo pygmaeus) from six different populations on the island of Borneo were determined and analyzed for evidence of regional diversity and were compared separately with orangutans from the island of Sumatra. Within the Bornean population, four distinct subpopulations were identified. Furthermore, the results of this study revealed marked divergence, supportive evidence of speciation between Sumatran and Bornean orangutans. This study demonstrates that, as an entire population, Bornean orangutans have not experienced a serious genetic bottleneck, which has been suggested as the cause of low diversity in humans and east African chimpanzees. Based on these new data, it is estimated that Bornean and Sumatran orangutans diverged approximately 1.1 MYA and that the four distinct Bornean populations diverged 860,000 years ago. These findings have important implications for management, breeding, and reintroduction practices in orangutan conservation efforts.

Asunto(s)

Variación Genética , Pongo pygmaeus/genética , Animales , Borneo , ADN Mitocondrial/análisis , ADN Mitocondrial/genética , Indonesia , Filogenia , Reacción en Cadena de la Polimerasa , Pongo pygmaeus/clasificación , Análisis de Secuencia de ADN , Programas Informáticos

RESUMEN

In two previous studies, we have demonstrated the successful protection of human immunodeficiency virus type 1 (HIV-1)-vaccinated rhesus macaques from challenge with SHIV(SF13) with envelop immunogens derived from the closely related HIV-1(SF2) strain. Here we report on two follow-up studies in which we aimed to broaden immunity in order to elicit protection from a more diverse heterologous challenge with SHIV(SF33). In the first study, animals were boosted once with HIV-1(SF33) V2 and V3 peptides that were cross-linked to influenza immune-stimulating complexes (ISCOMs). In the second study, monkeys were boosted twice at 12-week intervals, using a heterologous recombinant gp120 derived from HIV-1(SF33) that was either incorporated into ISCOMs or mixed with the MF59 adjuvant. In both studies, the animals were challenged with 50 monkey infectious doses of SHIV(SF33) 4 weeks after the final boost. All controls became readily infected with the heterologous challenge virus SHIV(SF33). Neither boosting with heterologous SF33 peptides or gp120 afforded protection from infection to SF2-vaccinated animals that had previously resisted SHIV(SF13) challenge. These results demonstrate the importance of developing vaccine strategies that are capable of generating broad immune responses early in the immunization protocol. Furthermore, these findings may illustrate the potential pitfalls of early antigenic sin.

Asunto(s)

Vacunas contra el SIDA/inmunología , VIH-1/inmunología , Proteínas del Envoltorio Viral/inmunología , Animales , Epítopos/inmunología , Proteína gp120 de Envoltorio del VIH/inmunología , Inmunización/veterinaria , Macaca mulatta , Orthomyxoviridae/inmunología , Fragmentos de Péptidos/inmunología , Virus de la Inmunodeficiencia de los Simios/inmunología , Vacunas Atenuadas/inmunología , Carga Viral

Asunto(s)

Virus de la Inmunodeficiencia Felina , Precursores de Proteínas/genética , Proteínas del Envoltorio Viral/genética , Animales , Gatos , Mutagénesis Sitio-Dirigida , Eliminación de Secuencia , Relación Estructura-Actividad

RESUMEN

A high prevalence (42.6%) of hepatitis B virus (HBV) infection was suspected in 195 formerly captive orangutans due to a large number of serum samples which cross-reacted with human HBV antigens. It was assumed that such viral infections were contracted from humans during captivity. However, two wild orangutans were identified which were HBV surface antigen positive, indicating that HBV or related viruses may be occurring naturally in the orangutan populations. Sequence analyses of seven isolates revealed that orangutans were infected with hepadnaviruses but that these were clearly divergent from the six known human HBV genotypes and those of other nonhuman hepadnaviruses reported. Phylogenetic analyses revealed geographic clustering with Southeast Asian genotype C viruses and gibbon ape HBV. This implies a common origin of infection within this geographic region, with cross-species transmission of hepadnaviruses among hominoids.

Asunto(s)

Enfermedades del Simio Antropoideo/virología , Infecciones por Hepadnaviridae/veterinaria , Hepadnaviridae/genética , Pongo pygmaeus/virología , Secuencia de Aminoácidos , Animales , Enfermedades del Simio Antropoideo/sangre , Enfermedades del Simio Antropoideo/inmunología , Secuencia de Bases , ADN Viral , Hepadnaviridae/clasificación , Hepadnaviridae/inmunología , Infecciones por Hepadnaviridae/sangre , Infecciones por Hepadnaviridae/inmunología , Infecciones por Hepadnaviridae/virología , Antígenos de Superficie de la Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/inmunología , Humanos , Datos de Secuencia Molecular , Filogenia , Homología de Secuencia de Aminoácido

RESUMEN

The kinetics of T-helper immune responses generated in 16 mature outbred rhesus monkeys (Macaca mulatta) within a 10-month period by three different human immunodeficiency virus type 1 (HIV-1) vaccine strategies were compared. Immune responses to monomeric recombinant gp120SF2 (rgp120) when the protein was expressed in vivo by DNA immunization or when it was delivered as a subunit protein vaccine formulated either with the MF59 adjuvant or by incorporation into immune-stimulating complexes (ISCOMs) were compared. Virus-neutralizing antibodies (NA) against HIV-1SF2 reached similar titers in the two rgp120SF2 protein-immunized groups, but the responses showed different kinetics, while NA were delayed and their levels were low in the DNA-immunized animals. Antigen-specific gamma interferon (IFN-gamma) T-helper (type 1-like) responses were detected in the DNA-immunized group, but only after the fourth immunization, and the rgp120/MF59 group generated both IFN-gamma and interleukin-4 (IL-4) (type 2-like) responses that appeared after the third immunization. In contrast, rgp120/ISCOM-immunized animals rapidly developed marked IL-2, IFN-gamma (type 1-like), and IL-4 responses that peaked after the second immunization. To determine which type of immune responses correlated with protection from infection, all animals were challenged intravenously with 50 50% infective doses of a rhesus cell-propagated, in vivo-titrated stock of a chimeric simian immunodeficiency virus-HIVSF13 construct. Protection was observed in the two groups receiving the rgp120 subunit vaccines. Half of the animals in the ISCOM group were completely protected from infection. In other subunit vaccinees there was evidence by multiple assays that virus detected at 2 weeks postchallenge was effectively cleared. Early induction of potent type 1- as well as type 2-like T-helper responses induced the most-effective immunity.

Asunto(s)

Vacunas contra el SIDA/inmunología , Síndrome de Inmunodeficiencia Adquirida/inmunología , Proteína gp120 de Envoltorio del VIH/inmunología , VIH-1/inmunología , ISCOMs/inmunología , Inmunidad Celular , Polisorbatos/farmacología , Escualeno/inmunología , Escualeno/farmacología , Vacunas contra el SIDA/química , Vacunas contra el SIDA/farmacología , Síndrome de Inmunodeficiencia Adquirida/prevención & control , Adyuvantes Inmunológicos/farmacología , Animales , Química Farmacéutica , Proteína gp120 de Envoltorio del VIH/farmacología , Humanos , ISCOMs/farmacología , Macaca mulatta , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/farmacología

RESUMEN

A serological survey of confiscated orangutans was conducted to determine the prevalence of specific viral infections cross reacting with human viruses. Antibodies specific for human hepatitis A (HAV) and B (HBV) viruses, herpes simplex viruses (HSV), and human T-lymphotropic virus (HTLV types I and II), as well as for the simian type D retroviruses (SRV types 1 to 3) and simian immunodeficiency virus (SIV) were tested in samples from 143 orangutans. Results revealed a high prevalence of potential pathogens. The most prevalent viral infection found was HBV (59.4% prevalence) of which 89.4% of infected individuals seroconverted to the non-infectious state and 10.6% remained as chronic carriers. Antibodies to HAV, HSV, HTLV-1, and SRV were also detected but at a lower prevalence. There was no evidence of lentiviral infections in this group of animals. The results confirm the importance of quarantine and the need for diagnostic differentiation of virus infections to determine if they are of human origin or unique orangutan viruses.

Asunto(s)

Anticuerpos Antivirales/sangre , Pongo pygmaeus , Enfermedades de los Primates/epidemiología , Virosis/veterinaria , Animales , Betaretrovirus/inmunología , Reacciones Cruzadas , Anticuerpos Anti-HTLV-I/sangre , Anticuerpos Anti-HTLV-II/sangre , Anticuerpos de Hepatitis A , Anticuerpos Antihepatitis/sangre , Anticuerpos contra la Hepatitis B/sangre , Herpesviridae/inmunología , Humanos , Indonesia , Prevalencia , Cuarentena/veterinaria , Síndrome de Inmunodeficiencia Adquirida del Simio/epidemiología , Virus de la Inmunodeficiencia de los Simios/inmunología , Virosis/epidemiología

RESUMEN

In a recent serological survey among 143 ex-captive orang-utans two individuals were found that reacted positive in an ELISA detecting antibodies which cross-react with human T-lymphotropic virus type I (HTLV-I) antigens. Infection of both animals with an HTLV-I or simian T-lymphotropic virus (STLV)-like virus was confirmed by Western blot analysis. A third wild-caught animal, which was not part of the original serological survey, was also found to be infected with an HTLV-related virus in a diagnostic PCR assay and Western blot assay. Nucleotide sequence analysis of the 709 bp PCR fragment from the tax/rex region of the HTLV/STLV genome confirmed infection of orang-utans with an STLV similar to but clearly distinct from other Asian STLVs.

Asunto(s)

Infecciones por Deltaretrovirus/veterinaria , Enfermedades de los Monos/virología , Pongo pygmaeus/virología , Virus Linfotrópico T Tipo 1 de los Simios/genética , Virus Linfotrópico T Tipo 1 de los Simios/inmunología , Secuencia de Aminoácidos , Animales , Animales Salvajes , Secuencia de Bases , Western Blotting , ADN Viral , Anticuerpos Antideltaretrovirus/sangre , Antígenos de Deltaretrovirus/inmunología , Infecciones por Deltaretrovirus/sangre , Infecciones por Deltaretrovirus/inmunología , Infecciones por Deltaretrovirus/virología , Ensayo de Inmunoadsorción Enzimática , Productos del Gen env/inmunología , Productos del Gen gag/inmunología , Productos del Gen rex/genética , Productos del Gen tax/genética , Humanos , Indonesia , Datos de Secuencia Molecular , Enfermedades de los Monos/sangre , Enfermedades de los Monos/inmunología , Filogenia , Pongo pygmaeus/sangre , Pongo pygmaeus/inmunología , Proteínas Oncogénicas de Retroviridae/inmunología , Homología de Secuencia de Aminoácido , Virus Linfotrópico T Tipo 1 de los Simios/clasificación , Productos del Gen env del Virus de la Inmunodeficiencia Humana , Productos del Gen gag del Virus de la Inmunodeficiencia Humana

RESUMEN

The cellular tropism of the feline immunodeficiency virus (FIV) is affected by changes in variable region 3 (V3) of the surface (SU) envelope glycoprotein (Verschoor, E. J., et al., J. Virol. 69:4752-4757, 1995). By using high-dose DNA transfection, an FIV molecular clone with a non-CRFK-tropic V3 acquired the ability to replicate in CRFK cells. A single point mutation from a methionine to a threonine in the ectodomain of its transmembrane (TM) envelope glycoprotein was responsible for this change in viral tropism. This substitution is located in the putative SU interactive region, between the fusion peptide and the membrane-spanning region. Our results show that this region of the TM envelope glycoprotein constitutes an additional determinant for cell tropism.

Asunto(s)

Glicoproteínas/fisiología , Virus de la Inmunodeficiencia Felina/fisiología , Proteínas del Envoltorio Viral/fisiología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Gatos , ADN , Glicoproteínas/genética , Metionina/metabolismo , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Proteínas del Envoltorio Viral/genética

RESUMEN

Subunit vaccines prepared against feline immunodeficiency virus (FIV) infection were evaluated in two trials. First, cats were immunized with bacterial expression products of an envelope fragment that contained the V3 neutralization domain of the FIV surface protein fused to either galactokinase (K-SU3) or glutathione-S-transferase (G-SU3). Quantitative and qualitative differences in the humoral immune response were observed with three adjuvants of which Quil A was the best in terms of total and virus neutralizing antibody. Notwithstanding the responses induced, 19 of 20 immunized cats did not resist challenge and became infected. To determine whether priming with a live viral vector would confer protection, cats were inoculated oronasally and subcutaneously with a feline herpesvirus (FHV) mutant expressing the FIV env gene; two booster immunizations followed using the K-SU3 product in either Quil A or a mineral oill Al(OH)3 adjuvant. FIV-specific antibody responses were only weak, and the vaccinates did not withstand challenge with a low dose of homologous virus.

Asunto(s)

Síndrome de Inmunodeficiencia Adquirida del Felino/prevención & control , Virus de la Inmunodeficiencia Felina/inmunología , Vacunas Virales/uso terapéutico , Animales , Anticuerpos Antivirales/análisis , Anticuerpos Antivirales/sangre , Gatos , Ensayo de Inmunoadsorción Enzimática , Estudios de Evaluación como Asunto , Síndrome de Inmunodeficiencia Adquirida del Felino/sangre , Productos del Gen env/biosíntesis , Productos del Gen env/genética , Productos del Gen env/inmunología , Virus de la Inmunodeficiencia Felina/genética , Vacunas Atenuadas/uso terapéutico , Proteínas Virales de Fusión/biosíntesis , Proteínas Virales de Fusión/genética , Proteínas Virales de Fusión/inmunología

RESUMEN

Feline immunodeficiency virus (FIV) isolates differ in the ability to replicate in Crandell feline kidney (CRFK) cells. The difference in tropism between two variants of the Dutch isolate FIV-UT113 was studied by using molecular clones which contained the envelope genes of the variants in a background of the FIV-14 Petaluma sequence. Virus produced from clone pPET-113Th replicated in thymocytes, whereas virus from pPET-113Cr propagated in both thymocytes and CRFK cells, thereby reflecting the phenotypes of the parental variants. Exchange of envelope gene fragments showed that a 464-bp surface protein (SU)-encoding fragment encompassing the third variable region (V3) determines CRFK cell tropism. Sequence analysis of the exchanged fragments demonstrated two amino acid changes that led to an increase of the overall charge of the V3 domain: a G-->R transition at position 397 and a E-->K change at position 407. Mutational analysis of these residues revealed that the E-->K shift was responsible for the change in tropism, while the G-->R mutation improved the replication kinetics in CRFK cells. Mapping of a tropism determinant for FIV to a region which is also a major neutralization domain is reminiscent of human immunodeficiency virus type 1, in which a similar colocation was found.

Asunto(s)

Virus de la Inmunodeficiencia Felina/fisiología , Mutación , Proteínas del Envoltorio Viral/fisiología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Gatos , Línea Celular , Clonación Molecular , Cartilla de ADN , Desoxirribonucleasa HindIII/metabolismo , Virus de la Inmunodeficiencia Felina/genética , Datos de Secuencia Molecular , Pruebas de Neutralización , Proteínas del Envoltorio Viral/genética , Replicación Viral/genética , Replicación Viral/fisiología

RESUMEN

Crandell feline kidney cells and feline thymocytes, either feline immunodeficiency virus (FIV) infected or uninfected, were fixed with paraformaldehyde and used to vaccinate cats. The cells were mixed with a 30:70 water/mineral oil emulsion containing 250 micrograms ml-1 N-acetyl-D-glucosaminyl-beta-(1-4)-N-acetyl-muramyl-L-alanyl-D-isoglutam ine. Eighteen specific pathogen-free cats were vaccinated three times with 3-week intervals and challenged 21 days after the final boost with a low dose of the homologous FIV-UT113 strain. Eight out of ten cats that had received FIV-infected cell vaccines developed significant anti-FIV antibody titres to the envelope and core antigens. Neutralizing antibodies were detectable at the moment of challenge in the sera of these animals. Within 5 weeks after challenge 15 out of 18 cats became viraemic. Three animals, two that had been vaccinated with FIV-infected thymocytes and did not develop antibody, and one that had received an uninfected thymocyte preparation, remained uninfected for 6 months. Upon rechallenge of the three animals, two again resisted infection; these cats had been immunized with the infected and the uninfected thymocyte preparations, respectively.

Asunto(s)

Síndrome de Inmunodeficiencia Adquirida del Felino/prevención & control , Virus de la Inmunodeficiencia Felina/inmunología , Vacunación/veterinaria , Vacunas Virales , Animales , Anticuerpos Antivirales/biosíntesis , Secuencia de Bases , Gatos , Línea Celular , Células Cultivadas , Cartilla de ADN/química , Síndrome de Inmunodeficiencia Adquirida del Felino/inmunología , Virus de la Inmunodeficiencia Felina/crecimiento & desarrollo , Riñón/citología , Riñón/virología , Complejo Mayor de Histocompatibilidad/inmunología , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa/veterinaria , Organismos Libres de Patógenos Específicos , Linfocitos T/virología , Fijación del Tejido , Proteínas Estructurales Virales/genética , Proteínas Estructurales Virales/inmunología , Vacunas Virales/inmunología , Viremia/inmunología , Viremia/prevención & control , Viremia/veterinaria

RESUMEN

A competitive reverse transcription-polymerase chain reaction (RT-PCR) was developed to quantify RNA of feline immunodeficiency virus (FIV) in cats. The assay uses in vitro synthesized RNA derived from the gag region of the FIV genome as a competitive internal control. The synthesized RNA has a 22-base deletion with respect to the wild-type sequence. PCR products were quantitated by densitometric analysis of a digitalized image of the ethidium bromide stained gel. The non-radioactive method was evaluated in reconstruction experiments. RNA synthesis in FIV-infected feline thymocytes correlated well with the amount of viral p24 antigen produced. Viral RNA concentrations in the plasma of two cats experimentally infected with FIV strain UT113 were followed for 32 weeks; peak copy numbers (2.3 x 10(4) and 1.3 x 10(4) per ml, respectively) were reached 11 weeks after subcutaneous injection of ten 50% cat infectious doses. With rising antibody titers against FIV-gag and FIV-env gene products, the amount of FIV RNA in plasma decreased. Nine asymptomatic cats that had been experimentally infected 3.5 to 4.5 years earlier had copy numbers between 5.6 x 10(3) and 4.3 x 10(4) per ml. This quantitative competitive RT-PCR will be useful to study the pathogenesis of the FIV infection, to evaluate the effectiveness of vaccines and to monitor antiviral and immunomodulating drugs.

Asunto(s)

Virus de la Inmunodeficiencia Felina/aislamiento & purificación , Reacción en Cadena de la Polimerasa/veterinaria , Animales , Secuencia de Bases , Enfermedades de los Gatos/virología , Gatos , Células Cultivadas , Cartilla de ADN , Síndrome de Inmunodeficiencia Adquirida del Felino/virología , Infecciones por Lentivirus/veterinaria , Infecciones por Lentivirus/virología , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa/métodos , ARN Viral/aislamiento & purificación , Timo/citología , Timo/virología , Transcripción Genética

RESUMEN

Overlapping fragments of the envelope protein of feline immunodeficiency virus (FIV) have been expressed in Escherichia coli. Screening of cat sera for antibodies to these fragments revealed that the immunodominant domain of the FIV envelope is localized within the transmembrane protein (amino acids 687-741) and that both the variable region 3 (SU3, aa 385-417) and the COOH-terminus (aa 599-611) of the surface protein (SU) are highly immunogenic. Of all rabbit sera raised to the envelope protein fragments only the serum directed to SU3 was neutralizing. Both FIV-infected and SU3-immunized cats elicited neutralizing antibodies to SU3. Neutralizing antibodies in sera of infected cats could be absorbed by SU3, showing that SU3 is a major neutralization domain of FIV.

Asunto(s)

Anticuerpos Antivirales/biosíntesis , Productos del Gen env/inmunología , Virus de la Inmunodeficiencia Felina/inmunología , Epítopos Inmunodominantes/inmunología , Secuencia de Aminoácidos , Animales , Anticuerpos Antivirales/sangre , Secuencia de Bases , Gatos , Productos del Gen env/análisis , Productos del Gen env/genética , Virus de la Inmunodeficiencia Felina/química , Epítopos Inmunodominantes/análisis , Datos de Secuencia Molecular , Pruebas de Neutralización , Proteínas Recombinantes de Fusión/análisis , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/inmunología

RESUMEN

The gag and env genes of the feline immunodeficiency virus strain UT113 were cloned into a baculovirus transfer vector. The recombinant plasmids were used to create recombinant baculoviruses that expressed either the gag or the env precursor protein in insect cells (Sf9 cells). Leader sequence cleavage occurred in Sf9 cells expressing the envelope precursor, but further processing was not observed. Crude lysates of insect cells infected with the wild-type baculovirus or with the recombinant viruses were used to develop an enzyme-linked immunosorbent assay for the detection of feline immunodeficiency virus-specific antibodies in cat sera. The assay showed a higher sensitivity and specificity than immunofluorescence and Western blotting (immunoblotting).

Asunto(s)

Síndrome de Inmunodeficiencia Adquirida del Felino/diagnóstico , Productos del Gen gag/biosíntesis , Virus de la Inmunodeficiencia Felina/inmunología , Precursores de Proteínas/biosíntesis , Proteínas del Envoltorio Viral/biosíntesis , Proteínas Virales , Animales , Baculoviridae/genética , Secuencia de Bases , Gatos , Línea Celular , Clonación Molecular , Ensayo de Inmunoadsorción Enzimática , Productos del Gen gag/inmunología , Glicosilación , Datos de Secuencia Molecular , Mariposas Nocturnas , Precursores de Proteínas/inmunología , Proteínas Recombinantes/inmunología , Proteínas del Envoltorio Viral/inmunología